VAMP-Associated Protein B (VAPB) Promotes Breast Tumor Growth by Modulation of Akt Activity

VAPB (VAMP- associated protein B) is an ER protein that regulates multiple biological functions. Although aberrant expression of VAPB is associated with breast cancer, its function in tumor cells is poorly understood. In this report, we provide evidence that VAPB regulates breast tumor cell proliferation and AKT activation. VAPB protein expression is elevated in primary and metastatic tumor specimens, and VAPB mRNA expression levels correlated negatively with patient survival in two large breast tumor datasets. Overexpression of VAPB in mammary epithelial cells increased cell growth, whereas VAPB knockdown in tumor cells inhibited cell proliferation in vitro and suppressed tumor growth in orthotopic mammary gland allografts. The growth regulation of mammary tumor cells controlled by VAPB appears to be mediated, at least in part, by modulation of AKT activity. Overexpression of VAPB in MCF10A-HER2 cells enhances phosphorylation of AKT. In contrast, knockdown of VAPB in MMTV-Neu tumor cells inhibited pAKT levels. Pharmacological inhibition of AKT significantly reduced three-dimensional spheroid growth induced by VAPB. Collectively, the genetic, functional and mechanistic analyses suggest a role of VAPB in tumor promotion in human breast cancer.

[1]  C. Raoul,et al.  Accumulation of Wildtype and ALS-Linked Mutated VAPB Impairs Activity of the Proteasome , 2011, PloS one.

[2]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[3]  E. Ikonen,et al.  Role of ORPs in Sterol Transport from Plasma Membrane to ER and Lipid Droplets in Mammalian Cells , 2011, Traffic.

[4]  A. Børresen-Dale,et al.  Identification of fusion genes in breast cancer by paired-end RNA-sequencing , 2011, Genome Biology.

[5]  V. Olkkonen,et al.  ALS-linked P56S-VAPB, an aggregated loss-of-function mutant of VAPB, predisposes motor neurons to ER stress-related death by inducing aggregation of co-expressed wild-type VAPB. , 2010, Journal of neurochemistry.

[6]  H. Stenmark.  Rab GTPases as coordinators of vesicle traffic , 2009, Nature Reviews Molecular Cell Biology.

[7]  V. Olkkonen,et al.  ALS‐linked P56S‐VAPB, an aggregated loss‐of‐function mutant of VAPB, predisposes motor neurons to ER stress‐related death by inducing aggregation of co‐expressed wild‐type VAPB , 2009 .

[8]  Paul Melançon,et al.  ADP-ribosylation Factor 1 Controls the Activation of the Phosphatidylinositol 3-Kinase Pathway to Regulate Epidermal Growth Factor-dependent Growth and Migration of Breast Cancer Cells* , 2008, Journal of Biological Chemistry.

[9]  Dana M. Brantley-Sieders,et al.  Eph receptors in breast cancer: roles in tumor promotion and tumor suppression , 2008, Breast Cancer Research.

[10]  Jin Chen,et al.  Eph receptors and Ephrins in cancer: common themes and controversies. , 2008, Cancer research.

[11]  S. Lev,et al.  Coordinated lipid transfer between the endoplasmic reticulum and the Golgi complex requires the VAP proteins and is essential for Golgi-mediated transport. , 2008, Molecular biology of the cell.

[12]  Zhi Hu,et al.  An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer. , 2008, Cancer research.

[13]  Anthony W. Zoghbi,et al.  The Amyotrophic Lateral Sclerosis 8 Protein VAPB Is Cleaved, Secreted, and Acts as a Ligand for Eph Receptors , 2008, Cell.

[14]  Christos G. Gkogkas,et al.  VAPB interacts with and modulates the activity of ATF6. , 2008, Human molecular genetics.

[15]  Alan Mackay,et al.  Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines , 2008, Laboratory Investigation.

[16]  Roy A Jensen,et al.  A human breast cell model of preinvasive to invasive transition. , 2008, Cancer research.

[17]  Dana M. Brantley-Sieders,et al.  The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling. , 2008, The Journal of clinical investigation.

[18]  S. Munro,et al.  The small G proteins of the Arf family and their regulators. , 2007, Annual review of cell and developmental biology.

[19]  Wen-Lin Kuo,et al.  A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. , 2006, Cancer cell.

[20]  Ajay N. Jain,et al.  Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. , 2006, Cancer cell.

[21]  K. Hanada,et al.  Efficient Trafficking of Ceramide from the Endoplasmic Reticulum to the Golgi Apparatus Requires a VAMP-associated Protein-interacting FFAT Motif of CERT* , 2006, Journal of Biological Chemistry.

[22]  I. Nishimoto,et al.  Characterization of Amyotrophic Lateral Sclerosis-linked P56S Mutation of Vesicle-associated Membrane Protein-associated Protein B (VAPB/ALS8)* , 2006, Journal of Biological Chemistry.

[23]  Crislyn D'Souza-Schorey,et al.  ARF proteins: roles in membrane traffic and beyond , 2006, Nature Reviews Molecular Cell Biology.

[24]  Christopher J. R. Loewen,et al.  A Highly Conserved Binding Site in Vesicle-associated Membrane Protein-associated Protein (VAP) for the FFAT Motif of Lipid-binding Proteins* , 2005, Journal of Biological Chemistry.

[25]  J. Foekens,et al.  Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer , 2005, The Lancet.

[26]  S. Lev,et al.  Differential Regulation of Endoplasmic Reticulum Structure through VAP-Nir Protein Interaction* , 2005, Journal of Biological Chemistry.

[27]  Zhijian Zhao,et al.  Allosteric Akt (PKB) inhibitors: discovery and SAR of isozyme selective inhibitors. , 2005, Bioorganic & medicinal chemistry letters.

[28]  T. Gillingwater,et al.  A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. , 2004, American journal of human genetics.

[29]  C. Arteaga,et al.  Overexpression of HER2 (erbB2) in Human Breast Epithelial Cells Unmasks Transforming Growth Factor β-induced Cell Motility* , 2004, Journal of Biological Chemistry.

[30]  Dana M. Brantley-Sieders,et al.  Increased Malignancy of Neu-Induced Mammary Tumors Overexpressing Active Transforming Growth Factor β1 , 2003, Molecular and Cellular Biology.

[31]  Jayanta Debnath,et al.  Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. , 2003, Methods.

[32]  Christopher J. R. Loewen,et al.  A conserved ER targeting motif in three families of lipid binding proteins and in Opi1p binds VAP , 2003, The EMBO journal.

[33]  S. Kagiwada,et al.  Role of the yeast VAP homolog, Scs2p, in INO1 expression and phospholipid metabolism. , 2003, Journal of biochemistry.

[34]  S. Hanks,et al.  An Eph receptor sperm-sensing control mechanism for oocyte meiotic maturation in Caenorhabditis elegans. , 2003, Genes & development.

[35]  A. Pozzi,et al.  Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo , 2002, Oncogene.

[36]  A. Spang.  ARF1 regulatory factors and COPI vesicle formation. , 2002, Current opinion in cell biology.

[37]  F. Kittrell,et al.  Nuclear Factor-κB (NF-κB) Regulates Proliferation and Branching in Mouse Mammary Epithelium , 2001 .

[38]  E. Kandel,et al.  Mouse VAP33 is associated with the endoplasmic reticulum and microtubules. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[39]  James M. Anderson,et al.  VAP-33 localizes to both an intracellular vesicle population and with occludin at the tight junction. , 1999, Journal of cell science.

[40]  Z. Elazar,et al.  Erg30, a Vap-33–Related Protein, Functions in Protein Transport Mediated by Copi Vesicles , 1999, The Journal of cell biology.

[41]  Y. Nishimura,et al.  Molecular cloning and characterization of mammalian homologues of vesicle-associated membrane protein-associated (VAMP-associated) proteins. , 1999, Biochemical and biophysical research communications.

[42]  A. Klip,et al.  Identification of a human homologue of the vesicle-associated membrane protein (VAMP)-associated protein of 33 kDa (VAP-33): a broadly expressed protein that binds to VAMP. , 1998, The Biochemical journal.

[43]  E. Kandel,et al.  A VAMP-binding protein from Aplysia required for neurotransmitter release. , 1995, Science.

[44]  C. Der,et al.  Rab1b regulates vesicular transport between the endoplasmic reticulum and successive Golgi compartments , 1991, The Journal of cell biology.

[45]  Jin Chen.  Regulation of tumor initiation and metastatic progression by Eph receptor tyrosine kinases. , 2012, Advances in cancer research.

[46]  Van,et al.  A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.

[47]  F. Kittrell,et al.  Nuclear factor-kappaB (NF-kappaB) regulates proliferation and branching in mouse mammary epithelium. , 2001, Molecular biology of the cell.